Skip to main content

Part of the book series: Verhandlungen der Deutschen Gesellschaft für innere Medizin ((VDGINNERE,volume 87))

  • 28 Accesses

Zusammenfassung

Osteoporose ist ein wesentliches Merkmal des chronischen Hyperkortisolismus. Glukokortikoide hemmen die Mineralisation und fördern den Nettoausstrom von Kalzium aus dem Skelett durch direkte Wirkungen auf den Osteozyten [1, 2], aber der Einfluß der Glukokortikoide auf die Homöostase von Kalizium gilt als weitere Ursache für die Mineralsalzverarmung des Knochens. Chronischer Hyperkortisolismus steigert die renale Kalziumausscheidung, und Behandlung mit Glukokortikoiden in pharmakologischer Dosis kann eine Abnahme der Kaliziumabsorption aus dem Verdauungstrakt hervorrufen [3], die offenbar dosisabhängig ist: sie wurde bei Therapie mit niedrigen Erhaltungsdosen nicht beobachtet [4, 5]. Beim endogenen Cushing-Syndrom ergaben frühere Messungen und einzelne Untersuchungen der Kalziumbilanz ebenfalls, daß die Kalziumabsorption erniedrigt war [6, 7]; Sjöberg [8] beobachtete aber bei einer Untersuchung an neun Patienten mit endogenem Cushing-Syndrom, daß die Retention von Kalzium aus einer Testmahlzeit normal war.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Hahn TJ (1980) Corticosteroid osteopenia. In: Drug-induced disorders of vitamin D and mineral metabolism. Clin Endocrinol Metabol 9: 107–129

    CAS  Google Scholar 

  2. Manolagas SC, Anderson DC (1979) Glucocorticoids regulate the concentration of 1,25-dihydroxychole-calciferol receptors in bone. Nature 277: 314–315

    Article  PubMed  CAS  Google Scholar 

  3. Gallagher JC, Aaron J, Horsman A, Wilkinson R, Nordin BEC (1973) Corticosteroid osteoporosis. Clin Endocrinol Metabol 2: 355–368

    Article  CAS  Google Scholar 

  4. Lekkerkerker JFF, van Woudenberg F, Doorenbos H (1972) Influence of low dose of steroid therapy on calcium absorption. Acta Endocrinol (Kbh) 69: 488–496

    CAS  Google Scholar 

  5. Klein RG, Arnaud SB, Gallagher JC, DeLuca HF, Riggs BL (1977) Intestinal calcium absorption in exogenous hypercortisolism: Role of 25-hydroxyvitamin D and corticosteroid dose. J Clin Invest 60: 253–259

    Article  PubMed  CAS  Google Scholar 

  6. Ewe K (1974) Die intestinale Calcium-Resorption und ihre Störungen. Klin Wochenschr 52:57–63, 64–73

    Article  PubMed  CAS  Google Scholar 

  7. Wilkinson R (1976) Absorption of calcium, phosphorus, and magnesium. In: Nordin BEC (ed) Calcium, phosphate, and magnesium metabolism. Churchill Livingstone, Edinburgh London New York, pp 36–112

    Google Scholar 

  8. Sjöberg HE (1979) Retention of orally administered 47Ca in man under normal and diseased conditions studied with a whole-body counter technique. Acta Med Scand (Suppl) 509: 1–28

    Google Scholar 

  9. Parker TF, Vergne-Marini P, Hull AR, Pak CYC, Fordtran JS (1974) Jejunal absorption and secretion of calcium in patients with chronic renal disease on hemodialysis. J Clin Invest 54: 358–365

    Article  PubMed  CAS  Google Scholar 

  10. Kley HK, Bartmann E, Krüskemper HL (1977) A simple and rapid method to measure non-protein-bound fractions of cortisol, testosterone and oestradiol by equilibrium dialysis: Comparison with centrifugal filtration. Acta Endocrinol (Kbh) 85: 209–219

    CAS  Google Scholar 

  11. Keck E, von Lilienfeld-Toal H, Krüskemper HL (1981) Protein binding assays for 25-hydroxyvitamin D, 24, 25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D in human plasma. J Clin Chem Clin Biochem (in press)

    Google Scholar 

  12. Seeman E, Kumar R, Hunder GG, Scott M, Heath H, Riggs BL (1980) Production, degradation, and circulating levels of 1,25-dihydroxyvitamin D in health and in chronic glucocorticoid excess. J Clin Invest 66: 664–669

    Article  PubMed  CAS  Google Scholar 

  13. Dhom G. Die Nebennierenrinde. In: Altenähr E, Böcker W, Dohm G, Gusek W, Heitz PhU, Klöppel G, Leitz H, Mitschke H, Saeger W, Schäfer HJ, Staub J-J, Steiner H (Hrsg) Pathologie der endokrinen Organe. S 729–945

    Google Scholar 

  14. Editorial (1980) The dexamethasone test and depression. Lancet 2: 730

    Google Scholar 

  15. Benkert O (1979) Biochemische Grundlagen der Depression. Klin Wochenschr 57: 651–660

    Article  PubMed  CAS  Google Scholar 

  16. Philipp M, Beyer J, Happ J, Krause U (1979) Endokrinologische Vorhersage der

    Google Scholar 

  17. Cook DM, Kendall JW, Allen JP, Lagerquist LG (1976) Clin Endocrinol 5: 303–312

    Article  CAS  Google Scholar 

  18. Fehm HL, Voigt KH, Kummer G, Pfeiffer EF (1979) J Clin Invest 64: 102–108

    Article  PubMed  CAS  Google Scholar 

  19. Jungmann E, Schulz F, Magnet W, Schöffling K (1981) Med Klin (im Druck )

    Google Scholar 

  20. Komanicky P, Spark RF, Melby JC (1978) J Clin Endocrinol Metab 47: 1042–1051

    Article  PubMed  CAS  Google Scholar 

  21. Potts GO, Creange JE, Harding HR, Schane HP (1978) Steroids 32: 257–267

    Article  PubMed  CAS  Google Scholar 

  22. Hajjar RA, Hickey RC, Samaan NA (1975) Adrenal cortical carcinoma. Cancer 35: 549–554

    Article  PubMed  CAS  Google Scholar 

  23. Hogan PF, Citrin DL, Johnson BM, Makamura S, Davis RE, Borden EC (1978) o,p’-DDD (mitotane) therapy of adrenal cortical carcinoma. Cancer 42: 2177–2181

    Article  PubMed  CAS  Google Scholar 

  24. Hutter AM, Kayhoe DE (1966) Adrenal cortical carcinoma. Am J Med 41: 581–592

    Article  PubMed  Google Scholar 

  25. Kelly WF, Barnes AJ, Cassar J, White M, Mashiter K, Loizou S, Welbourn RB, Joplin GF (1979) Cushing’s syndrome due to adrenocortical carcinoma a comprehensive clinical and biochemical study of patients treated by surgery and chemotherapy. Acta Endocrinol (Kbh) 91: 303–318

    CAS  Google Scholar 

  26. King DR, Lack EE (1979) Adrenal cortical carcinoma. Cancer 44: 239–244

    Article  PubMed  CAS  Google Scholar 

  27. Lipsett MB, Wilson H (1962) Adrenocortical cancer: steroid biosynthesis and metabolism evaluated by urinary metabolites. J Clin Endocrinol Metab 22: 906–915

    Article  PubMed  CAS  Google Scholar 

  28. Lubitz JA, Freeman L, Okun R (1973) Mitotane use in inoperable adrenal cortical carcinoma. JAMA 223: 1109–1112

    Article  PubMed  CAS  Google Scholar 

  29. Luton JP, Mahoudeau JA, Bouchard Ph, Thieblot Ph, Hautecouverture M, Simon D, Laudat MH, Touitou Y, Bricaire H (1979) Treatment of Cushing’s disease by o,p’-DDD. N Engl J Med 300: 459–464

    Article  PubMed  CAS  Google Scholar 

  30. Chopra IJ (1976) An assessment of daily production and significance of thyroidal 3,3’,5’tryodthyronine (reserve T3) in man. J Clin Invest 58: 32

    Article  PubMed  CAS  Google Scholar 

  31. Grün M, Liehr H, Rasenack U (1977) Die modifizierte portocavale Anastomose der Ratte (mPCA). Klinische Untersuchungen zur Pathogenese des Eck-Fistel-Syndroms. Verh Dtsch Ges Inn Med 83: 507

    Google Scholar 

  32. Grün M (1978) Biologische Auswirkungen einer portocavalen Anastomose. Berichte d. Physik. chem. Ges. zu Würzburg. Neue Folge 86: 1

    Google Scholar 

  33. Grün M, Richter E (Unveröffentlichte Ergebnisse)

    Google Scholar 

  34. Grün R (unveröffentlichte Ergebnisse)

    Google Scholar 

  35. Kaplan MM, Utiger RD (1978) Iodothyronine metabolism in rat liver homogenates. J

    Google Scholar 

  36. Clin Invest 61: 459

    Google Scholar 

  37. Miller LJ, Gorman CA, Go VLW (1978) Gut-thyroid interrelationships. Gastroenterology 75: 901

    PubMed  CAS  Google Scholar 

  38. Rudorff K-H, Hermann J, Strohmeyer G, Krüskemper HL (1978) Schilddrüsenfunktionsparameter bei Lebererkrankungen. Med Welt 29: 1888

    PubMed  CAS  Google Scholar 

  39. Pennisi F, Romelli PB, Vancheri L (1979) Measurement of free thyroid hormones in serum by column adsorption chromatography and radio-immunoassay. In: Free thyroid hormones. Proceedings of the International Symposium held in Venice, December 1978. Excerpta Medica, Amsterdam, pp 93–102

    Google Scholar 

  40. Ekins RP (1979) Methods for the measurement of free thyroid hormones. In: Free thyroid hormones. Proceedings of the International Symposium held in Venice, December 1978. Excerpta Medica, Amsterdam, pp 72–92

    Google Scholar 

  41. Blichert-Toft M, Egedorf J, Christiansen C, Axelsson CK (1979) Function of pituitary-thyroid axis after surgical treatment of non-toxic nodular goiter. Acta Med Scand 206: 15–19

    Article  PubMed  CAS  Google Scholar 

  42. Galvan G, Gattinger A, Krüttner H, Maier F, Manzl M (1979) Die Bedeutung des TRH-Tests für Indikation und Überwachung der Rezidiv-Prophylaxe und Strumaresektion. Nuc Compact 10: 261–264

    Google Scholar 

  43. Gemsenjäger E (1976) Untersuchungen der Schilddrüsenfunktion mittels TRH-Testes bei blander Struma vor und nach Strumektomie. Schweiz Med Wochenschr 106: 1084–1089

    PubMed  Google Scholar 

  44. Hör G, Kohlhoff U, Bottermann P, Nitz D, Schmid L, Langhammer H, Pabst HW (1978): Radioimmunologische TSH-Spiegelkontrollen vor und nach TRH-Gabe bei 350 Patienten nach Strumaresektion. Med Klin 73: 945–951

    PubMed  Google Scholar 

  45. Keltz D (1980) Ergebnisse einer postoperativen Schilddrüsenhormontherapie bei 542 Patienten. Dissertation, Düsseldorf

    Google Scholar 

  46. Kremer K (1977) Therapie der Struma aus der Sicht des Chirurgen. Vortrag NEDICA ‘77 Düsseldorf

    Google Scholar 

  47. Pickardt CR, Erhardt F, Horn K, Lehnert P, Scriba PC (1974) Therapeutische Suppression der TSH-Sekretion bei blander Struma, Rezidivstruma und zur Rezidivprophylaxe nach Strumaresektion. Verh Dtsch Ges Inn Med 80: 1352–1355

    PubMed  CAS  Google Scholar 

  48. Steiner H (1977) Rezidivprophylaxe nach Schilddrüsenoperationen. Wien Med Wochenschr 127: 161–168

    PubMed  CAS  Google Scholar 

  49. Wahl R (1979) Gesichtspunkte zur funktionellen Schilddrüsenchirurgie auf der Basis der heutigen radioimmunologischen Bestimmungsmethoden. Habilitationsschrift, Heidelberg

    Google Scholar 

  50. Wahl R, Hornstein Ch, Grussendorf M, Meybier H, Höfner M, Röher HD (1978) Ansätze zu einer differenzierten Rezidivprophylaxe nach Strumaoperation. Langenbecks Arch Chir (Suppl) 161

    Google Scholar 

  51. Weber MJ, Hefti E, Wetz B, Kinser J (1980) Die Wirkung einer Rezidivprophylaxe vier bis fünf Jahre nach einer Strumaoperation. Hely Chim Acta 47: 7–10

    CAS  Google Scholar 

  52. Billewicz WZ, Chapman RS, Crooks J, Day ME, Cossage J, Wayne E, Young JA (1969) Statistical methods applied to the diagnosis of hypothyroidism. Q J Med 38: 255

    PubMed  CAS  Google Scholar 

  53. Milton RC (1964) Extended table of critic values for the Mann-Whitney-Wilcoxon two-sample statistic. J Am Statist Ass 59: 925

    Article  Google Scholar 

  54. Balsam A, Leppo LE (1975) Effect of physical training on the metabolism of thyroid hormones in man. J Appl Physiol 38: 212–215

    PubMed  CAS  Google Scholar 

  55. Irvine CHG (1968) Effect of exercise on thyroxine degradation in athletes and non-athletes. J Clin Endocrinol Metab 28: 942–948

    Article  PubMed  CAS  Google Scholar 

  56. Kaciuba-UtciFko H, Greenleaf JE, Kozloswki S, Nazar K, Ziemba A (1975) Thyroid hormone-induced changes in body temperature and metabolism during exercise in dogs. Am J Physiol 229: 260–264

    Google Scholar 

  57. Refsum HE, Strömme SB (1979) Serum thyroxine, triiodothyronine and thyroid stimulating hormone after prolonged heavy exercise. Scand J Clin Lab Invest 39: 455–459

    Article  PubMed  CAS  Google Scholar 

  58. Terjung RL, Tipton CM (1971) Plasma thyroxine and thyroid-stimulating hormone levels during submaximal exercise in humans. Am J Physiol 220: 1840–1845

    PubMed  CAS  Google Scholar 

  59. Winder WW, Heninger RW (1971) Effect of exercise on tissue levels of thyroid hormones in the rat. Am J Physiol 221: 1139–1143

    PubMed  CAS  Google Scholar 

  60. Wirth A, Holm G, Lindstedt G, Lundberg P-A, Björntorp P (1981) Thyroid hormones and lipolysis in physically trained rats. Metabolism (in press)

    Google Scholar 

  61. Botsch H, Schulz E, Lochner B (1979) Serum-Thyreoglobulinbestimmung zur Verlaufskontrolle bei Schilddrüsenkarzinom-Patienten. Dtsch Med Wochenschr 104: 1072–1074

    Article  PubMed  CAS  Google Scholar 

  62. Gärtner R, Horn K, Pickhardt RC (1980) Improvement of the diagnostic validity of the thyroglobulin radioimmunoassay. Acta Endocrinol [Suppl 234] (Kbh) 94: 30–31

    Google Scholar 

  63. Hüfner M, Pollmann H, Grussendorf M, Schenk P (1980) Die Bedeutung der Thyreoglobulinbestimmung im Serum bei der Nachsorge von Patienten mit differenziertem Schilddrüsenkarzinom. Schweiz Med Wochenschr 110: 159–162

    PubMed  Google Scholar 

  64. Schneider AB, Pervos R (1978) Radioimmunoassay of human thyroglobulin: Effect of antithyroglobulin autoantibodies. J Clin Endocrinol Metab 47: 126–137

    Article  PubMed  CAS  Google Scholar 

  65. Shlossberg AH, Jacobsen JC, Ibbertson HK (1979) Serum thyroglobulin in the diagnosis and management of thyroid carcinoma. Clin Endocrinol 10: 17–27

    Article  CAS  Google Scholar 

  66. Tang Fui SCN, Hoffenberg R, Maisey MN, Black EG (1979) Serum thyroglobulin concentrations and whole-body radiodine scan in follow-up of differentiated thyroid cancer after thyroid ablation. Br Med J 2: 298–300

    Article  Google Scholar 

  67. Van Herle AJ, Uller RP (1975) Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinomas. J Clin Invest 56: 272–277

    CAS  Google Scholar 

  68. Van Herle AJ, Vassart G, Dumont JE (1979) Control of thyroglobulin synthesis and secretion (Part I and II). N Engl J Med 301: 239–249, 307–314

    Article  PubMed  Google Scholar 

  69. Baumann K, Weitzel M, Bürgi H (1979) Hormonproduzierendes Schilddrüsenkarzinom mit Hyperthyreose. Schweiz Med Wochenschr 109: 309–314

    PubMed  CAS  Google Scholar 

  70. Dobyns BM, Sheline GE, Workman JB (1974) Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: A report of the cooperative thyrotoxicosis therapy follow-up study. J Clin Endocrinol Metab 38: 976–998

    Article  PubMed  CAS  Google Scholar 

  71. Gärtner R, Horn K, Pickardt CR (1980) Improvement of the diagnostic validity of the thyroglobulin radioimmunoassay. Acta Endocrinol [Suppl] (Kbh) 234: 30

    Google Scholar 

  72. Habermann J, Pickardt CR, Scriba PC (1980) Interaction of TSH and “TSI” with thyroid membranes. Acta Endocrinol [Suppl] (Kbh) 234: 27

    Google Scholar 

  73. Hancock BW, Bing RF, Dirmikis SM, Munro DS, Neal FE (1977) Thyroid carcinoma and concurrent hyperthyroidism. Cancer 39: 298–302

    Article  PubMed  CAS  Google Scholar 

  74. Löhrs U (1976) Die pathologische Anatomie der Struma maligna. Chirurg 47: 413–421

    PubMed  Google Scholar 

  75. Oberdisse K, Klein E, Reinwein D (Hrsg) (1980) Die Krankheiten der Schilddrüse, 2. Aufl. Thieme, Stuttgart

    Google Scholar 

  76. Shands EC, Gatling RR (1970) Cancer of the thyroid: Review of 109 cases. Trans South Surg Ass 81: 124–132

    Google Scholar 

  77. Doniach D (1978) Lab Lore 497–499

    Google Scholar 

  78. Schleusener H, Finke R, Kotulla P, et al. (1978) J Endocrinol 155–161

    Google Scholar 

  79. Rose NR (1978) Arch Intern Med 527–528

    Google Scholar 

  80. McGregor AM, Petersen

    Google Scholar 

  81. MM, McLachlan SMN, et al. (1980) N Engl J Med 302–307

    Google Scholar 

  82. Heide D v d, Bolk JH, Bruin TWA, et al. (1980) Lancet 1376–1380

    Google Scholar 

  83. McGregor AM, McLachlan S, Clark F, et al. (1979) Immunology 81–85

    Google Scholar 

  84. Bonnys M, Cano P, Osterland CK, et al. (1978) Am J Med 971–977

    Google Scholar 

  85. Balazs C, Leövey A, Szabo M, et al. (1980) Eur J Clin Pharmacol 19–23

    Google Scholar 

  86. Brattig N, Berg PA (1976) Clin Exp Immunol 40–49

    Google Scholar 

  87. Brodie BB, Davies JI, Hynie S, Krishna G, Weiss B (1966) Interrelationship of catecholamines with other endocrine systems. Pharmacol Rev 18: 273–289

    PubMed  CAS  Google Scholar 

  88. Ericson LE, Hakanson R, Melander A, Owman CH, Sundler F (1970) Endocytosis of thyroglobulin and release of thyroid hormone in mice by catecholamines and 5-hydroxy tryptamine. Endocrinology 87: 915–923

    Article  PubMed  CAS  Google Scholar 

  89. Feely J, Forrest A, Gunn A, Hamilton W, Stevenson I, Crooks J (1980) Propranolol dosage in thyrotoxicosis. J Clin Endocrinol Metab 51: 658–661

    Article  PubMed  CAS  Google Scholar 

  90. Kallner G, Ljunggren JG, Tryselius M (1978) The effect of propranolol on serum levels of T4, T3 and reverse-T3 in hyperthyroidism. Acta Med Scand 204: 35–37

    Article  PubMed  CAS  Google Scholar 

  91. Loos U, Rothenbuchner G (1977) Schilddrüse and vegetatives Nervensystem. In: Sturm A, Birkmayer W (Hrsg) Klinische Pathologie des vegetativen Nervensystems. Fischer, Stuttgart New York, S 1688–1716

    Google Scholar 

  92. Maayan ML, Shapiro R, Ingbar SH (1973) Epinephrine precursors: effects on the iodine and intermediary metabolism of isolated calf thyroid cells. Endocrinology 92: 912–916

    Article  PubMed  CAS  Google Scholar 

  93. Melander A, Sundler F, Westgren U (1973) Intrathyroidal amines and the synthesis of thyroid hormone. Endocrinology 93: 193–200

    Article  PubMed  CAS  Google Scholar 

  94. Pannier JL (1968) The influence of thyroid hormone on myocardial contractility. Arch Int Physiol 76: 477–490

    Article  PubMed  CAS  Google Scholar 

  95. Teevarwerk GJM, Malik MH, Boyd D (1978) Preliminary report on the use of propranolol in thyrotoxicosis: I. Effect on serum thyroxine, triiodothyronine and reverse-triiodothyronine concentrations. Can Med Assoc J 119: 350–360

    Google Scholar 

  96. Teevarwerk GJM, Boyd D (1979) Propranolol in thyrotoxicosis: II. Serum thyroid hormone concentrations during subtotal thyroidectomy. Can J Surg 22: 264–266

    Google Scholar 

  97. Theilade P, Hansen JM, Skovsted L, Faber J, Kirkegaard C, Friis T, Siersbaeck-Nielsen K (1977) Propranolol influences serum T3 and reverse-T3 in hyperthyroidism. Lancet 2: 363

    Article  PubMed  CAS  Google Scholar 

  98. Wildenthal K (1974) Studies of fetal mouse hearts in organ culture: influence of prolonged exposure to triiodothyronine on cardiac responsiveness to isoproterenol, glucagon, theophylline, acetylcholine and dibutyryl cyclic 3’,5’-adenosine monophosphate. J Pharmacol Exp Ther 190: 272–279

    PubMed  CAS  Google Scholar 

  99. Williams LT, Lefkowitz RJ, Watanabe AM (1977) Thyroid hormone regulation of beta-adrenergic receptor number. J Biol Chem 252: 2787–2789

    PubMed  CAS  Google Scholar 

  100. Caplan RH, Glasser JE, Davis K, Foster L, Wickus G (1978) Thyroid function tests in elderly hyperthyroid patients. J Am Geriatr Soc 25: 116–120

    Google Scholar 

  101. Davis PJ, Faith BD (1974) Medicine 53: 161–181

    Article  PubMed  CAS  Google Scholar 

  102. Emrich D, Bähre M (1978) Autonomy in euthyroid goitre: maladaptation to iodine deficiency. Clin Endocrinol (Oxf) 8: 257–265

    Article  CAS  Google Scholar 

  103. Ingbar SH (1976) Effect of aging on thyroid economy in man. J Am Geriatr Soc 24: 49–53

    PubMed  CAS  Google Scholar 

  104. Lahey FH (1931) Non-activated (apathetic) type of hyperthyroidism. N Engl J Med 204: 747–748

    Article  Google Scholar 

  105. Mahlstedt J, Joseph K (1973) Dekompensation autonomer Adenome der Schilddrüse nach prolongierter Jodzufuhr. Dtsch Med Wochenschr 98: 1748–1751

    Article  PubMed  CAS  Google Scholar 

  106. McGee RR, Whittacker RL, Tullis IF (1959) Apathetic thyroidism: review of the literature and report of four cases. Ann Intern Med 50: 1418–1432

    Article  PubMed  CAS  Google Scholar 

  107. ROknov-Jessen V, Kirkegaard C (1973) Hyperthyroidism

    Google Scholar 

  108. a disease of old age? Br Med J 1: 41–43

    Google Scholar 

  109. Stiel JN, Hales IB, Reeve TS (1972) Thyrotoxicosis in an elderly population. Med J Aust 2: 986–988

    PubMed  CAS  Google Scholar 

  110. Weinreich J, Nagel F, Groh R (1974) Die Altershyperthyreose im endemischen Kropfgebiet. Med Klin 69: 375–378

    PubMed  CAS  Google Scholar 

  111. Baldet L, Jaffiol C (1980) Clin Endocrinol (Oxf) 13: 393

    Article  CAS  Google Scholar 

  112. Bayer M, Ross McDougall I (1980) Clin Chem 26: 1186

    PubMed  CAS  Google Scholar 

  113. Bohner J, Geiseler D, Kallee E (1980) Aktuel Endokrinol 1: 235

    CAS  Google Scholar 

  114. Braverman LE, Abreau CM, Brock P, Kleinmann R, Fournier L, Odstrchel G, Schoemaker HJ (1980) J Nucl Biol Med 21: 233

    CAS  Google Scholar 

  115. Demers LM (1979) Clin Chem 25: 1349

    PubMed  CAS  Google Scholar 

  116. Ekins R (1979) Lancet 1: 1191

    Article  PubMed  CAS  Google Scholar 

  117. Emrich D, Leipert K-P, Schreivogel I, Facorro U, Köbberling J (1980) Aktuel Endokrinol 1: 245

    CAS  Google Scholar 

  118. Fichte H, Reiners Chr, Börner W, Moll E (1980) Nuklearmediziner 3: 229

    Google Scholar 

  119. Herrmann J, Krüskemper HL (1971) Z Klin Chem 9: 320

    CAS  Google Scholar 

  120. Odstrchel G, Hertl W, Ward FB, Travis K, Lindner RE, Mason RD (1978) Radioimmunoassay and related procedures in medicine 1977, vol II. IAEA, Wien

    Google Scholar 

  121. Rudorff K-H, Herrmann J, Horster FA, Krüskemper HL (1979) Nuklearmediziner 2: 2

    Google Scholar 

  122. Sterling K, Brenner MA (1966) J Clin Invest 45: 153

    Article  PubMed  CAS  Google Scholar 

  123. Szpunar WE, Block M, Bednarz MN, Stoffer SS (1980) J Nucl Biol Med 21: 576

    CAS  Google Scholar 

  124. Witherspoon LR, Shuler SE, Garcia MM, Zollinger LA (1980) J Nucl Biol Med 21: 529

    CAS  Google Scholar 

  125. Yeo PPB, Lewis M, Evered DC (1977) Clin Endocrinol (Oxf) 6: 159

    Article  CAS  Google Scholar 

  126. Weir GC, Knowlton SD, Martin DB (1974) Glucagon secretion from the perfused rat pancreas. J Clin Invest 54: 1403–1412

    Article  PubMed  CAS  Google Scholar 

  127. Gerich JE, Karam JH, Forsham PH (1973) Stimulation of glucagon secretion

    Google Scholar 

  128. by epinephrine in man. J Clin Endocrinol Metab 37: 479–481

    Google Scholar 

  129. De Fronzo RA, Felig P, Ferrannini E, Wahren J (1980) Effect of graded doses of insulin on splanchnic and peripheral potassium metabolism in man. Am J Physiol 238: 421–427

    Google Scholar 

  130. Daughaday WH (1974) The adenohypophysis. In: Williams RH (ed) Textbook of endocrinology, 5. edn. Saunders, Philadelphia London Toronto, p 31

    Google Scholar 

  131. Kühnau J, Stahnke N, Schrader D, Wilke H, Nowakowski H (1979) Alterations in carbohydrate metabolism in acromegaly before and after selective adenomectomy. Acta Endocrinol [Suppl] (Kbh) 225: 198

    Google Scholar 

  132. Liebermeister H, Solbach HG, Schilling WH, Ruenauver R, Meissner H, Grüneklee D, Herberg L, Daweke H (1968) Serum insulin in acromegaly. Diabetologia 4: 195

    Article  PubMed  CAS  Google Scholar 

  133. Chisholm DJ, Lazarus L, Young JD (1972) Secretin and insulin release in acromegaly. J Clin Endocrinol Metab 35: 108

    Article  PubMed  CAS  Google Scholar 

  134. Nikkilä EA, Pelkonen R (1975) Serum lipids in acromegaly. Metabolism 24: 829

    Article  PubMed  Google Scholar 

  135. Levin SR, Hofeldt JD, Schneider V, Becker N, Karam JH, Seymour RS, Adams JE, Forsham PH (1974) Cryohypophysectomy for acromegaly: Factors associated with altered endocrine function and carbohydrate metabolism. Am J Med 57: 526

    Article  PubMed  CAS  Google Scholar 

  136. Eastman RC, Gorden P, Roth J (1979) Conventional supervoltage irradiation is an effective treatment for acromegaly. J Clin Endocrinol Metab 48: 931

    Article  PubMed  CAS  Google Scholar 

  137. Pelkonen R, Grahne B (1975) Treatment of acromegaly by transsphenoidal hypophysectomy with cryoapplication. Clin Endocrinol (Oxf) 4: 53

    Article  Google Scholar 

  138. Summers VK, Hipkin LJ, Diver MJ, Davis JC (1975) Treatment of acromegaly with bromocriptine. J Clin Endocrinol Metab 40: 904

    Article  PubMed  CAS  Google Scholar 

  139. Thorner MO, Chait A, Aitken M, Benker G, Bloom SR, Mortimer CH, Sanders P, Stuart Mason A, Besser GM (1975) Bromocriptine treatment of acromegaly. Br Med J 1: 299

    Article  PubMed  CAS  Google Scholar 

  140. Althoff PH, Neubauer M, Basch M, Böttger B, Wild K von, Schöffling K (1978) Acromegaly and bromocriptine results of long-term treatment. In: Fahlbusch R, Werder K von (eds) Treatment of pituitary adenomas. Thieme, Stuttgart

    Google Scholar 

  141. Halse J, Haugen HN, Bohmer T (1977) Bromocriptine treatment in acromegaly: Clinical and biochemical aspects. Acta Endocrinol (Kbh) 86: 464

    PubMed  CAS  Google Scholar 

  142. Sachdev Y, Tunbridge WMG, Weightman DR, Gomez-Pan A, Duns A, Hall R, Goolamali SK (1975) Bromocriptine therapy in acromegaly. Lancet 2: 1164

    Article  PubMed  CAS  Google Scholar 

  143. Wass JAH, Cudworth AG, Bottazzo GF, Woodrow JC, Besser GM (1980) An assessment of glucose intolerance in acromegaly and its response to medical treatment. Clin Endocrinol (Oxf) 12:53 —15. Kahn CR (1980) Role of insulin receptors in insulin-resistant states. Metabolism 29: 455

    Article  Google Scholar 

  144. Dietze G, Wicklmayr M (1977) Klin Wschr 55: 357

    Article  PubMed  CAS  Google Scholar 

  145. Wicklmayr M, Dietze G (1977) In: Haberland GL, Rohen JW, Suzuki T (eds) Kinogenases. Schattauer, Stuttgart, S 299

    Google Scholar 

  146. Dietze G, Wicklmayr M, Böttger I, Mayer L (1978) Hoppe Seylers Z Physiol Chem 359: 1209

    Article  PubMed  CAS  Google Scholar 

  147. Wicklmayr M, Dietze G

    Google Scholar 

  148. Mayer L, Böttger I, Grunst J (1979) FEBS Lett 98: 61

    Article  PubMed  Google Scholar 

  149. Wicklmayr M, Dietze G, Günther B, Mayer L, Böttger I, Geiger R, Schultis K (1978) Klin Wochenschr 56: 1077

    Article  PubMed  CAS  Google Scholar 

  150. Wicklmayr M, Dietze G (1979) FEBS Lett 106: 125

    Article  PubMed  CAS  Google Scholar 

  151. Rohen JW, Haberland GL (1977) Med Welt 28: 30

    PubMed  CAS  Google Scholar 

  152. Schifman R, Dietze G, Wicklmayr M, Mehnert H, Böttger I (1980) Verh Dtsch Ges Inn Med 86: 988

    CAS  Google Scholar 

  153. Parnas I, Wagner R (1921) Biochem Z 125: 253

    CAS  Google Scholar 

  154. Ross H, Johnston IDA, Welbron FA, Wright AD (1966) Lancet 1: 563

    Article  Google Scholar 

  155. Wright PD, Henderson K, Johnston IDA (1974) Br J Surg 61: 5

    Article  PubMed  CAS  Google Scholar 

  156. Hirsch EF, Nakajima T, Oshima G, Erdös EG, Herman CM (1974) J Surg Res 17: 147

    Article  PubMed  CAS  Google Scholar 

  157. Hetzel WD, Nierle CH, Pfeiffer EF (1977) Analytical study on the effect of GnRH (Des-Gly-10-D-Leu-6)ethylamide. Acta Endocrinol [Suppl] (Kbh) 208: 35–36

    Google Scholar 

  158. Knobil E, Plant TM, Wildt L, Beldetz PE, Marshall G (1980) Control of the rhesus monkey menstrual cycle: Permissive role of hypothalamic gonadotropin-releasing hormone. Science 207: 1371–1373

    Article  PubMed  CAS  Google Scholar 

  159. Leyendecker G, Struve T, Plotz EJ (1980) Ovulationsauslösung durch pulsatorische LH-RH-Gabe. Arch Gynaekol 229: 177–190

    CAS  Google Scholar 

  160. Wickings EJ, Brabant G, Zaidi P, Nieschlag E (1981) Spontaneous or pump-induced LH-spikes as requirement for full testicular function in rhesus monkeys. Acta Endocrinol [Suppl] (Kbh) 240: 74

    Google Scholar 

  161. Frayley EE, Lange PH, Kennedy MD (1979) Germ-cell testicular cancer in adults ( First of two parts ). N Engl J Med 301: 1370–1377

    Article  Google Scholar 

  162. Javadpour N (1980) The role of biologic tumor markers in testicular cancer. Cancer 45: 1755–1761

    Article  PubMed  CAS  Google Scholar 

  163. Mann K, Lamerz R, Hellmann T, Kümper HJ, Staehler G, Karl HJ (1980) Use of human chorionic gonadotropin and alpha-fetoprotein radioimmunoassays: specificity and apparent half-life determination after delivery and in patients with germ cell tumours. Oncodevelopmental Biology and Medicine 1: 301–312

    PubMed  CAS  Google Scholar 

  164. Mann K, Gilch R, Haidl P, Hellmann T, Hammerl B, Karl HJ (1980) Methodological aspects in the determination of human chorionic gonadotropins and its subunits. J Clin Chem Clin Biochem 18: 733

    Google Scholar 

  165. Rosen SW, Weintraub BD (1974) Ectopic production of the isolated alpha subunit of the glycoprotein hormones. N Engl J Med 290: 1441–1447

    Article  PubMed  CAS  Google Scholar 

  166. Barbezat GO, Isenberg JI, Grossman MI (1972) Diuretic action of secretin in dog. Proc Soc Exp Biol Med 139: 211–215

    Article  PubMed  CAS  Google Scholar 

  167. Baron DN, Newman F, Warwick A (1958) The effects of secretin on urinary volume and electrolytes in normal subjects and patients with chronic pancreatic disease. Experientia 14: 30–32

    Article  CAS  Google Scholar 

  168. Becker HD (1980) Behandlung blutender Schleimhauterosionen des Magens mit Sekretin. Z Gastroenterol 18: 334–336

    PubMed  CAS  Google Scholar 

  169. Forrest JN, Reichlin S, Goodman DBP (1980) Somatostatin: An endogenous peptide in the toad urinary bladder inhibits vasopressin-stimulated water flow. Proc Natl Acad Sci USA 77: 4984–4987

    Article  CAS  Google Scholar 

  170. Henn RM, Selcon S, Sturdevant RAL, Isenberg JI, Grossman MI (1976) Experience with synthetic secretin in the treatment of duodenal ulcer. Am J Dig Dis 21: 921–925

    Article  PubMed  CAS  Google Scholar 

  171. Höj L, Holst JJ, Rune J (1973) A trial of exogenous secretin in the treatment of duodenal ulcer pain. Scan J Gastroenterol 8: 279–281

    Google Scholar 

  172. Kayasseh L, Gyr K, Keller U, Stalder GA, Wall M (1980) Somatostatin and cimetidine in peptic-ulcer haemorrhage. Lancet 1: 844–846

    Article  PubMed  CAS  Google Scholar 

  173. Keller U, Sonnenberg GE, Kayasseh L, Gyr K, Perruchoud A (1979) Dosisabhängigkeit der Wirkung von Somatostatin auf die splanchnische Durchblutung beim Menschen. Schweiz Med Wochenschr 109: 595–596

    PubMed  CAS  Google Scholar 

  174. Konturek SJ, Biernat J, Olesky J (1974) Serum gastrin and gastric acid response to meals at various pH levels in man. Gut 15: 526–530

    Article  PubMed  CAS  Google Scholar 

  175. Londong W, Geier E, Feifel G, Forell MM (1975) Hypoglykämieinduzierte Gastrinfreisetzung nach Vagotomie. Z Gastroenterol 13: 418–423

    Google Scholar 

  176. Londong W, Londong V, Prechtl R, Weber T, von Werder K (1980) Interactions of cimetidine and pirenzepine on peptone-stimulated gastric acid secretion in man. Scand J Gastroenterol [Suppl 66]15: 103–112

    Article  CAS  Google Scholar 

  177. Londong W, Londong V, Hanssen LE, Schwanner A (1981) Gastric effects and side effects of synthetic secretin in man. Regulatory Peptides 2 (in press)

    Google Scholar 

  178. Reid IA, Rose JC (1977) An intrarenal effect of somatostatin on water excretion. Endocrinology 100: 782–785

    Article  PubMed  CAS  Google Scholar 

  179. Ruoff HJ, Becker M (1981) Histamine sensitive adenylate cyclase in human gastric mucosa: cellular localisation and interaction by PGE2, somatostatin and secretin. 10th Meeting of the Europ. Histamine Research Society, Hannover 12–15 May

    Google Scholar 

  180. Schmidt F (1971) Methoden der Ham-und Blutzuckerbestimmung. In: Pfeiffer EF (ed) Handbook of diabetes mellitus, vol II. Lehmann, München, p 913

    Google Scholar 

  181. Usadel KH, Leuschner U, Überla KK (1980) Treatment of acute pancreatitis with somatostatin: a multicenter double-blind trial. N Engl J Med 303: 181

    Google Scholar 

  182. Wagner PK, Rothmund M (1980) Effekt von Cimetidin und Sekretin bei akuten Blutungen aus Magen und Duodenum Ergebnisse einer prospektiven alternierenden Studie. Z Gastroenterol 18: 337–341

    PubMed  CAS  Google Scholar 

  183. Wahren J, Felig P (1976) Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus. Lancet 2: 1213–1216

    Article  PubMed  CAS  Google Scholar 

  184. Weber H (1965) Mikromethode zur Bestimmung der Pankreaslipase im Serum. Dtsch Med Wochenschr 90: 1170–1174

    Article  PubMed  CAS  Google Scholar 

  185. Weichselbaum TE (1946) An accurate and rapid method for the determination of proteins in small amounts of blood serum and plasma. Am J Cl in Pathol 16: 40–49

    Google Scholar 

  186. Johansson C, Wisén O, Kollberg B, Uvnäs-Wallensten K, Efendic S (1978) Effects of intragastrically administered somatostatin on basal and pentagastrin stimulated gastric acid secretion in man. Acta Physiol Scand 104: 232–234

    Article  PubMed  CAS  Google Scholar 

  187. Raptis S, Rosenthal J (1977) Somatostatin potential diagnostic and therapeutic value. Acta Hepatogastroenterol (Stuttg) 24: 61–63

    CAS  Google Scholar 

  188. Schusdziarra V, Rouiller D, Unger RH (1979) Oral administration of somatostatin reduces postprandial plasma triglycerides, gastrin, and gut glucagon-like immunoactivity. Life Sci 24: 1595–1600

    Article  PubMed  CAS  Google Scholar 

  189. Brinton GS, Jubiz W, Lagerquist LD (1975) Hypertension in primary hyperparathyroidism: the role of the renin-angiotensin-system. J Clin Endocrinol Metab 41: 1025–1029

    Article  PubMed  CAS  Google Scholar 

  190. Epstein S, Sagel J, Brodovcky H, Tuff S, Eales L (1976) Absence of an acute effect of calcium or parathyroid hormone administration on plasma renin activity in man. Clin Sci Mol Med 50: 79–81

    PubMed  CAS  Google Scholar 

  191. Goltzman D, Henderson B, Loveridge N (1980) Cytochemical bioassay of parathyroid hormone. J Clin Invest 65: 1309–1317

    Article  PubMed  CAS  Google Scholar 

  192. Hehrmann R, Wilke R, Nordmeyer JP, Hesch R-D (1976) Hochsensitiver, C-terminal-spezifischer Radioimmunoassay für menschliches Parathormon als Routinemethode. Dtsch Med Wochenschr 101: 1726–1729

    PubMed  CAS  Google Scholar 

  193. Lindner A, Treman JA, Plantier J, Chapman W, Forrey AW, Haines G, Palmieri GM (1978) Effects of parathyroid hormone on the renal circulation and renin secretion in unasthetized dogs. Mineral Electrolyte Metab 1: 155–165

    CAS  Google Scholar 

  194. Parsons JA, Rafferty B, Gray D, Reit B, Zanelli JM, Keutman HT, Tregear GW, Callaghan EN, Potts JT (1975) Pharmacology of parathyroid hormone and some of its fragments and analogues. In: Talmage RV, Owen M, Parsons JA (eds) Calcium-regulating hormones. Excerpta Medica, Amsterdam, p 33–39

    Google Scholar 

  195. Powell HR, Rotenberg E, McCredie DA, Cornell H (1977) Parathyroid hormone-renin interrelationships. Aust Paediatr J 13: 59

    Google Scholar 

  196. Powell HR, McCredie DA, Rotenberg E (1978) Renin release by parathyroid hormone in the dog. Endocrinology 103: 985–989

    Article  PubMed  CAS  Google Scholar 

  197. Scholz H-C, Nordmeyer JP, Jüppner H, Liebau H, Hesch R-D (1980) PTH-action on vasoactive and diuretic hormones. Acta Endocrinol [Suppl] (Kbh) 234: 124–125

    Google Scholar 

  198. Smith JM, Mouw DR, Vander AJ (1979) Effect of parathyroid hormone on plasma renin activity and sodium excretion. Am J Physiol 236: F311 — F319

    PubMed  CAS  Google Scholar 

  199. D’Amour P et al. (1979) J Clin Invest 63: 89

    Article  PubMed  Google Scholar 

  200. Naumann WF et al. (1975) Calcif Tissue Res 18: 251

    Article  Google Scholar 

  201. Martin et al. (1980) Phosphate and minerals in health and disease. In: Massay S, Ritz E, Jahn H (eds) Press, New York, p 485

    Google Scholar 

  202. Fisch M et al. (1980) Chir. Form 80. Langenbecks Arch Chir [Suppl], S 145

    Google Scholar 

  203. Lee C et al. (1958) Med J Aust 1: 40

    Google Scholar 

  204. Abonna et al. (1972) Surgery 72: 537

    Google Scholar 

  205. Hehrmann R et al. (1976) Dtsch Med Wochenschr 101: 1726

    PubMed  CAS  Google Scholar 

  206. Freitag J et al. (1978) Engl J Med 298: 29

    Article  CAS  Google Scholar 

  207. Collins KJ, Weiner JS (1968) Endocrinological aspects of exposure to high environmental temperatures. Physiol Rev 48: 785–839

    PubMed  CAS  Google Scholar 

  208. Lignières B de et al. (1976) Sécrétion testiculaire d’androgènes après effort physique prolongé chez l’homme. Nouv Presse Méd 5: 2060–2064

    PubMed  Google Scholar 

  209. Wüst G (1975) HGH, corticoids, insulin, and glucose in serum during hyperthermia and effect of somatostatin in male volunteers. In: Proceedings of the International Symposium on Cancer Therapy by Hyperthermia and Radiation, Washington, DC, 28.-30. April 1975, pp 303–305

    Google Scholar 

  210. Ayvazian LF, Schneider B, Gewirtz G, Yalow RS (1979) Amer Rev Respir Dis 111: 279

    Google Scholar 

  211. Gewirtz G, Yalow RS (1974) J Clin Invest 53: 1022

    Article  PubMed  CAS  Google Scholar 

  212. Hansen M, Hummer L (1979) In: Muggia FM, Rosenczweig M (eds) Lung cancer: Progress in therapeutic research. Raven Press, New York, p 199

    Google Scholar 

  213. Havemann K, Gropp C (1980) Internist 21: 84

    PubMed  CAS  Google Scholar 

  214. Rees LH (1975) J Endocrinol 67: 143

    Article  PubMed  CAS  Google Scholar 

  215. Wolfsen AR, Odell WD (1979) Am J Med 66: 765

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

K. Miehlke

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Peerenboom, H. et al. (1981). Endokrinologie. In: Miehlke, K. (eds) Verhandlungen der Deutschen Gesellschaft für innere Medizin. Verhandlungen der Deutschen Gesellschaft für innere Medizin, vol 87. J.F. Bergmann-Verlag, Munich. https://doi.org/10.1007/978-3-642-47092-9_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-47092-9_11

  • Publisher Name: J.F. Bergmann-Verlag, Munich

  • Print ISBN: 978-3-8070-0327-6

  • Online ISBN: 978-3-642-47092-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics